Autor(es)

Reis-de-Oliveira, G. ^[1] ; Zuccoli, G. S. ^{[1, 2]} ; Fioramonte, M. ^{[1, 2]} ; Schimitt, A. ^{[3, 4]} ; Falkai, P. ^[4] ; Almeida, V ^{[1, 2]} ; Martins-de-Souza, D. ^{[5, 1, 6, 7, 2]}

Afiliação do(s) autor(es)

^[1] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Lab Neuroprote, UNICAMP, Campinas, SP - Brazil

^[2] Schimitt, A., Univ Sao Paulo, Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo, Brazil.Reis-de-Oliveira, G., Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Lab Neuroprote, UNICAMP, Campinas, SP - Brazil

^[3] Univ Sao Paulo, Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo - Brazil

^[4] Ludwig Maximilian Univ LMU, Dept Psychiat & Psychotherapy, Munich - Germany

^[5] Conselho Nacl Desenvolvimento Cient & Tecnol, Inst Nacl Biomarcadores Neuropsiquiatria INBION, Sao Paulo - Brazil

^[6] DOr Inst Res & Educ IDOR, Sao Paulo - Brazil

^[7] Univ Estadual Campinas, Expt Med Res Cluster EMRC, Campinas, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: JOURNAL OF PROTEOMICS; v. 223, JUL 15 2020.
• Citações Web of Science: 1

Resumo

Schizophrenia is a psychiatric disorder that affects 21 million people worldwide. Despite several studies having been shown that some brain regions may play a critical role in the pathophysiology o f schizophrenia, the mo lecular basis to explain this diversity is still lacking. The cerebellum (CER), caudate nucleus (CAU), and posterior cingulate cortex (PCC) are areas associated with negative and cognitive symptoms in schizophrenia. In this study, w e performed shotgun proteomics o f the aforementioned brain regions, collected postmortem from pa tients with schizophrenia and compared with the mentally healthy group. In addition, w e performed a proteomic analysis o f nuclear and mitochondrial fractions of these same regions. Our results presented 106, 727 and 135 differentially regulated proteins in the CAU, PCC, and CER, respectively. Pathway enrichment analysis revealed dysfunctions associated with synaptic processes in the CAU, transport in the CER, and in energy metabolism in the PCC. In all brain areas, w e found that proteins related to oligodendrocytes and the metabolic processes were dysregulated in schizophrenia. Significance: Schizophrenia is a complex and heterogeneous psychiatric disorder. Despite much research having been done to increase the knowledge about the role o f each region in the pathophysiology o f this disorder, the molecular mechanisms underlying it are still lacking. We performed shotgun proteomics in the postmortem cerebellum (CER), caudate nucleus (CAU) and posterior cingulate cortex (PCC) from patients with schizophrenia and compared with healthy controls. Our findings suggest that each aforementioned region presents dysregulations in specific molecular pathways, such as energy metabolism in the PCC, transport in the CER, and synaptic process in the CAU. Additionally, these areas presented dysfunctions in oligodendrocytes and metabolic processes. Our results may highlight future directions for the development of novel clinical approaches for specific therapeutic targets. (AU)

• Processo FAPESP: 17/25588-1 - Da compreensão básica a biomarcadores clínicos para a esquizofrenia: um estudo multidisciplinar centrado na neuroproteômica
• Beneficiário: Daniel Martins-de-Souza
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 18/14666-4 - Influência do sistema endocanabinóide sobre o perfil energético de células neurais durante o neurodesenvolvimento: implicações na Esquizofrenia
• Beneficiário: Giuliana da Silva Zuccoli
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 18/03673-0 - Efeitos bioquímicos de canabinóides em oligodendrócitos: implicações para a esquizofrenia
• Beneficiário: Daniel Martins-de-Souza
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 17/18242-1 - Vias bioquímicas moduladas por drogas canabinóides em oligodendrócitos humanos
• Beneficiário: Valéria de Almeida
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 19/00098-7 - EMU concedido no processo 2017/25588-1: cromatógrafo Acquity UPLC I-Class
• Beneficiário: Daniel Martins-de-Souza
• Modalidade de apoio: Auxílio à Pesquisa - Programa Equipamentos Multiusuários
• Processo FAPESP: 16/18715-4 - Estabelecimento do papel de hnRNPs envolvidas em esquizofrenia através do mapeamento de suas redes de interação
• Beneficiário: Mariana Fioramonte
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 18/01410-1 - Avaliação dos efeitos da clozapina em células do sistema imune
• Beneficiário: Guilherme Reis-De-Oliveira
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
• Processo FAPESP: 14/10068-4 - EMU concedido no processo 13/08711-3: espectrômetro de massas Waters SYNAPT G2-Si HDMs + nanoACQUITY UPLC
• Beneficiário: Daniel Martins-de-Souza
• Modalidade de apoio: Auxílio à Pesquisa - Programa Equipamentos Multiusuários